Canaccord Genuity's Joseph Vafi dramatically cuts his MicroStrategy price target from $474 to $185, citing Bitcoin's failure to act as a safe haven and its heightened correlation with risk assets amid the prolonged crypto downturn.
The London-based tax advisory firm assembles a cross-sector council of industry leaders to help clients maximize R&D tax incentives amid regulatory reforms and rapid market changes.
Microsoft's latest quarterly earnings showcased robust revenue growth and profitability, yet a cautious outlook and heavy AI infrastructure investments have sparked a significant stock sell-off, raising questions about future margins and execution.
Blockchain analytics firm TRM Labs achieves unicorn status after a $70 million Series C funding round with participation from Goldman Sachs and Citi Ventures, as demand for cryptocurrency transaction tracing surges among law enforcement and financial institutions.
Fox Corporation reported a 2% rise in revenue to $5.18 billion for its second fiscal quarter of 2026, propelled by resilient advertising pricing and distribution gains that offset a decline in political ad spending. While profits dipped due to higher sports rights costs, streaming services Tubi and Fox One showed significant audience growth.
A product delay at Rigetti Computing and a strategic acquisition by IonQ are highlighting the starkly different execution strategies and risk profiles within the competitive quantum computing sector, forcing investors to reassess valuations.
Financial firm Rothschild & Co. Redburn has downgraded PayPal Holdings Inc. (PYPL) from Neutral to Sell, slashing its price target to $50, citing concerns over eroding market share in the face of aggressive competition from newer payment platforms.
In a pivotal Senate hearing, Netflix executives faced intense scrutiny over their proposed acquisition of Warner Bros. assets, ultimately persuading lawmakers that the vertical merger would fuel competition, preserve American jobs, and fortify the nation's cultural exports against global rivals.
Yum China Holdings, Inc. (NYSE: YUMC) reported robust fourth-quarter results for 2025, surpassing analyst forecasts for both revenue and adjusted earnings, driven by strategic brand initiatives and expansion into lower-tier cities.
A sharp decline in Actuate Therapeutics' market valuation last week has disproportionately impacted its major private equity shareholders, who control a dominant stake in the biopharmaceutical firm. The stock's recent performance puts a spotlight on ownership structure and its influence on risk.
Boston Scientific (NYSE:BSX) reported fourth-quarter revenue of $5.29 billion, aligning with Wall Street forecasts and marking a 15.9% year-over-year increase. The medical device giant also posted adjusted earnings of $0.80 per share, slightly above consensus, while providing guidance in line with expectations for the coming quarter.
The JioBlackRock joint venture has launched a personalised digital investment advisory service, leveraging BlackRock's Aladdin technology and Jio's vast digital network to offer tailored portfolio management starting at an entry point of ₹10,000.
Amid a strong start for major indices, a look at three lesser-known companies where recent insider buying activity hints at underlying value and management confidence.
While the OBBBA extends tax relief to millions, analysis shows high-income filers are positioned to capture a disproportionate share of the benefits, raising questions about the law's equity.
The AI boom is proving to be a double-edged sword for the technology sector. While some giants soar, a sharp selloff in software and services stocks highlights the market's growing discrimination between potential beneficiaries and those facing disruption from new AI tools.
The social media management platform's stock continues its precipitous fall, raising serious questions about its path to profitability and testing the patience of long-term investors.
A sharp sell-off last week erased $60 million from Omeros Corporation's market value, with its predominantly retail shareholder base feeling the deepest impact. The decline highlights the risks and influence of individual investors in the biotech firm's ownership structure.
After a month-long blockade, the United Nations has secured approval from Houthi authorities to resume vital humanitarian air services to Sanaa this February, offering a lifeline to millions amid Yemen's deepening crisis.
Raymond James reported year-over-year revenue growth in its fourth quarter, driven by record net new assets and robust advisor recruitment, though results slightly missed analyst forecasts. While its private client arm showed resilience, declining M&A activity weighed on overall performance.
The midstream energy giant Enterprise Products Partners reports record volumes and cash flows, setting the stage for continued expansion and a sustainable 6.7% yield.
